Search for drugs:

TEDIZOLID PHOSPHATE


DIR Classification


Classification:Ambiguous
Severity Score:1.0

Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF

  • CLINICAL PHARMACOLOGY
  • Pharmacodynamics
  • Cardiac Electrophysiology
  • In a randomized, positive- and placebo-controlled crossover thorough QTc study, 48 enrolled subjects were administered a single oral dose of SIVEXTRO at a therapeutic dose of 200 mg, SIVEXTRO at a supratherapeutic dose of 1200 mg, placebo, and a positive control; no significant effects of SIVEXTRO on heart rate, electrocardiogram morphology, PR, QRS, or QT interval were detected. Therefore, SIVEXTRO does not affect cardiac repolarization.

Postmarketing Surveillance

Contingency Table:

Current Drug
Other Drugs
QT Prolongation
0
24092
Other ADRs
0
38381587

Odds Ratio = N/A

Drug Property Information



ATC Code(s):
  • J01XX11 - tedizolid phosphate
    • J01XX - Other antibacterials
    • J01X - OTHER ANTIBACTERIALS
    • J01 - ANTIBACTERIALS FOR SYSTEMIC USE
    • J - ANTIINFECTIVES FOR SYSTEMIC USE
Active Ingredient:tedizolid phosphate
Active Ingredient UNII:O7DRJ6R4DW
Drugbank ID:DB09042
PubChem Compound:11476460
CTD ID:C515040
PharmGKB:
CAS Number:856867-55-5
Dosage Form(s):injection, powder, lyophilized, for solution; tablet, film coated
Route(s) Of Administrator:intravenous; oral
Daily Dose:
  • 200.0 mg/day J01XX11
Chemical Structure:
SMILE Code:
CN1N=NC(=N1)C1=CC=C(C=N1)C1=CC=C(C=C1F)N1C[C@H](COP(O)(O)=O)OC1=O

Reference

1: Effects of therapeutic and supratherapeutic doses of oral tedizolid phosphate on cardiac repolarisation in healthy volunteers: a randomised controlled study.

[Flanagan Shawn,Litwin Jeffrey,Fang Edward,Prokocimer Philippe]
Int J Antimicrob Agents,2016 Jul;48(1):33-40. PMID: 27342387

Disclaimer:

The content of this database of QT prolongation is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.

Any mention of commercial products is for clarification and not intended as endorsement.